CureSound Overview
CureSound specializes in noninvasive medical devices and is the developer of the BRH-A wound-healing series. The BRH-A2 is a noninvasive, FDA-cleared portable device designed to heal chronic ulcers, reduce the size of lesions, lessen wound pain, and accelerate tissue regrowth through a combination of therapeutic ultrasound and electrostimulation in modulating cycles of independent and joint activity. CureSound won the 8200 Israeli Startup Competition in June 2013.
Cumulative Funding Raised Over Time ($)
$600KDec 2013
Latest News
growth-positive
FDA Cleares BRH-A2 to Treat Serious Wounds Using Electric Fields and Ultrasound
BRH Medical, based in Jerusalem, Israel, has received FDA clearance for its BRH-A2 system that uses ultrasound and electricity to heal deep and chronic wounds. The device speeds up wound healing and reduces pain during treatment by delivering electric fields and ultrasound energy into and under the wound. It can be used in combination with other therapeutic methods and includes a patient and wound management system. BRH Medicals technology combines therapeutic ultrasound and electrostimulation to stimulate fibroblasts and create collagen, resulting in a more ordered and tighter collagen weave. The companys website provides more information about the BRH-A2 device and its capabilities.
Customers
growth-positive
BRH Medical Receives Patents in Both the USA and in China for Its Innovative Wound Healing Therapy
BRH Medical has been issued patents in the USA and China for its innovative wound healing system. The patents cover the treatment of various types of skin ulcers and the advanced documentation technology integrated into the system. The CEO of BRH Medical, Motti Oderberg, believes that obtaining patents in these markets is an important step in penetrating these large and growing markets. The companys wound treatment solution, based on ultrasound and electric fields, has been clinically proven to reduce wound pain and accelerate healing. BRH Medical aims to become the gold standard for the treatment of chronic wounds of all kinds.
Customers
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $600K |
| Last funding | $600K |
| Stage | Mature |
| Rounds | 1 |
| Investors | 1 |
Team Members
5
Employees: 1-10
Web & Social Links
| Website | www.curesound.co/ |
Locations
Jerusalem Technology Park, Jerusalem, Israel
Photos & Videos
4 item(s)
CureSound Business
Business models
B2C, B2B
Product stage
Released
Employees
1-10
Sector
Health Tech & Life SciencesMedical DevicesMedical Treatment & TherapeuticsTarget Customer
ConsumersDemographics & FamilySeniorsHealthcare & Life SciencesHealthcareProvidersPatientsCore Technology
Simulation & ImagingTags (15)
home-careulcersultrasoundmedical-devicesnon-invasivetherapeuticsdiabeteshealthcare-providersdoctorsclinicsseniorspain-reliefchronic-patientstreatmentsgymGeographic Markets
South AfricaGlobalIndiaCureSound Financials
$600K
Total funding
Undisclosed
Capital raised
$600K
Last funding
Mature
Funding stage
1
Total rounds
1
Investors
Cumulative Funding Raised Over Time ($)
$600KDec 2013
Private Equity Funding
Seed
Dec 2013
$600K
Undisclosed Investor(s)
CureSound Lifecycle
Cumulative Funding Raised Over Time
$600KDec 2013
All Events
Seed
Dec 2013
$600K
Undisclosed Investor(s)
CureSound News
2 articles
growth-positive
FDA Cleares BRH-A2 to Treat Serious Wounds Using Electric Fields and Ultrasound
BRH Medical, based in Jerusalem, Israel, has received FDA clearance for its BRH-A2 system that uses ultrasound and electricity to heal deep and chronic wounds. The device speeds up wound healing and reduces pain during treatment by delivering electric fields and ultrasound energy into and under the wound. It can be used in combination with other therapeutic methods and includes a patient and wound management system. BRH Medicals technology combines therapeutic ultrasound and electrostimulation to stimulate fibroblasts and create collagen, resulting in a more ordered and tighter collagen weave. The companys website provides more information about the BRH-A2 device and its capabilities.
Customers
growth-positive
BRH Medical Receives Patents in Both the USA and in China for Its Innovative Wound Healing Therapy
BRH Medical has been issued patents in the USA and China for its innovative wound healing system. The patents cover the treatment of various types of skin ulcers and the advanced documentation technology integrated into the system. The CEO of BRH Medical, Motti Oderberg, believes that obtaining patents in these markets is an important step in penetrating these large and growing markets. The companys wound treatment solution, based on ultrasound and electric fields, has been clinically proven to reduce wound pain and accelerate healing. BRH Medical aims to become the gold standard for the treatment of chronic wounds of all kinds.
Customers
CureSound Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 6 |
| Team members | 5 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 11 classification IDs that could be used for matching.
CureSound Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 100/100 |
| BI Verification | Sharon Shapira |
| Registrar ID | 514499482 |
| Crunchbase | brh-medical-curesound |
| Phone | +97226483541 |
| Creator | Raz Zohar |
| Creator email | raz@platterz.ca |
| Last updater | Natasha Voloshin |
| Updater email | natashavolo@gmail.com |
| Last update | 2020-12-16T00:00:00.000Z |
| Created | 2014-09-28T00:00:00.000Z |
| Claimed | Yes |